Vaishali Sanchorawala MD
Professor of Medicine, Director, Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MassachusettsDr. Vaishali Sanchorawala is the Professor of Medicine and Director of the Amyloidosis Center of Boston University School of Medicine and Boston Medical Center. She has been one of the pioneers in the field of clinical research in AL amyloidosis. Her work in the treatment of AL amyloidosis has been published in many peer-reviewed journals, which has resulted in the evolution of the standard of care for these patients. She is currently heading several clinical trials in the treatment of AL amyloidosis. She serves on the executive steering committee of the Amyloidosis Research Consortium, the board of the International Society of Amyloidosis as secretary, chair of the membership committee of the International Society of Amyloidosis and as an associate editor of Amyloid, Journal of Protein Folding Disorders. She has helped to create and cultivate the next generation of physician-scientists in the area of clinical research in AL amyloidosis.
Disclosures
Research Support/P.I.: Celgene, Millennium-Takeda, Janssen, Prothena, Sorrento, Karyopharm, Oncopeptide, Caelum, AlexionConsultant: Pfizer, Janssen, Attralus
Scientific Advisory Board: Proclara, Caelum, Abbvie, Janssen, Regeneron, Protego, Pharmatrace, Telix, Prothena, AstraZenec